Department of Animal Science, University of Zanjan, Zanjan, Iran 45371-38791.
Azarnegin Agro-Industry Complex, Tabriz, Iran 53551-85674.
J Dairy Sci. 2023 Oct;106(10):7320-7328. doi: 10.3168/jds.2022-22671. Epub 2023 May 8.
Recent studies have shown that cows with subclinical hypocalcemia (SCH) at 4 d in milk (DIM), regardless of their blood Ca concentration before that time point, suffer from an increased early-lactation disease risk and reduced milk yield, whereas cows experiencing a transient reduction in blood Ca that regain normocalcemia by 4 DIM are at a reduced risk of disease and have greater milk yields. With a goal of improving outcomes for dyscalcemic cows with SCH at 4 DIM, our primary objective was to assess the effect of a herd-level oral Ca bolus strategy that delayed supplementation to 24 and 48 h postpartum on productive performance of multiparous Holstein cows. Our secondary objectives were to assess the effects of delayed Ca bolus supplementation on blood Ca concentration, disease incidence within 30 DIM, and pregnancy risk to first service. At calving, multiparous cows on a single commercial dairy farm in Iran were randomly assigned to 1 of 3 treatment groups: (1) control, no Ca bolus administration (CON; n = 95); (2) traditional bolus, one Ca bolus administered immediately following calving and a second Ca bolus administered 24 h after calving (TRD, n = 102); or (3) experimental bolus, one Ca bolus administered 24 h after calving with a second Ca bolus administered 48 h after calving (EXP, n = 99). Blood samples were collected at 0, 24, 48, 72, and 96 h, and 7 d after parturition, with sampling occurring before bolus administration for the TRD (0 and 24 h) and EXP (24 and 48 h) groups. A general linear mixed model was created to analyze the change milk yield over the first 4 monthly tests and serum Ca concentrations over 7 DIM. Given the lack of disease events diagnosed within 30 DIM, no statistical analysis was conducted for this outcome. The effect of treatment group on risk of pregnancy to first service was assessed using Poisson regression. The incidence of dyscalcemia within CON cows was 72%. We found no difference in mean monthly milk yield among treatment groups across the first 4 tests, with an average monthly production of 51.8 ± 8.8 kg/d for CON cows, 52.5 ± 8.7 kg/d for TRD cows, and 51.8 ± 8.7 kg/d for EXP cows. Mean blood Ca concentration also did not differ across 7 DIM among treatment groups and was 2.04 mmol/L [95% confidence interval (CI) = 2.00 to 2.07 mmol/L] for CON cows, 2.06 mmol/L (95% CI = 2.03 to 2.09 mmol/L) for TRD cows, and 2.09 mmol/L (95% CI = 2.05 to 2.12 mmol/L) for EXP cows. The risk of pregnancy to first service was numerically greater for CON than TRD and EXP cows but not statistically different; however, our study was underpowered for this outcome. Under the conditions of our study, our findings suggest that delaying oral Ca bolus supplementation to 24 and 48 h postpartum has no effect on milk production across the first 4 monthly tests.
最近的研究表明,产后 4 天(DIM)患有亚临床低钙血症(SCH)的奶牛,无论在此之前的血钙浓度如何,都面临着更高的早期泌乳疾病风险和产奶量降低的风险,而那些经历过血钙短暂下降并在产后 4 天内恢复正常血钙水平的奶牛,患病风险降低,产奶量更高。为了改善产后 4 天患有 SCH 的奶牛的结果,我们的主要目标是评估延迟至产后 24 小时和 48 小时给予群体口服钙丸策略对荷斯坦奶牛多产奶牛生产性能的影响。我们的次要目标是评估延迟钙丸补充对血钙浓度、产后 30 天内疾病发病率和首次配种妊娠风险的影响。在伊朗的一个单一商业奶牛场,多产奶牛在分娩时被随机分配到 3 个治疗组中的 1 个:(1)对照组,不给予钙丸(CON;n = 95);(2)传统钙丸,产后立即给予 1 次钙丸,产后 24 小时给予第 2 次钙丸(TRD,n = 102);或(3)实验钙丸,产后 24 小时给予 1 次钙丸,产后 48 小时给予第 2 次钙丸(EXP,n = 99)。在产后 0、24、48、72 和 96 小时和产后 7 天采集血样,TRD(0 和 24 小时)和 EXP(24 和 48 小时)组在钙丸给药前进行采样。创建了一个一般线性混合模型来分析前 4 个月测试期间的产奶量变化和产后 7 天的血清钙浓度。由于在产后 30 天内没有诊断出疾病事件,因此没有对这一结果进行统计分析。使用泊松回归评估治疗组对首次配种妊娠风险的影响。CON 组奶牛的低钙血症发生率为 72%。我们发现,在首次 4 次测试中,各组间的平均月产奶量没有差异,CON 组奶牛的平均月产奶量为 51.8 ± 8.8 kg/d,TRD 组奶牛为 52.5 ± 8.7 kg/d,EXP 组奶牛为 51.8 ± 8.7 kg/d。7 天的平均血钙浓度在各组间也没有差异,CON 组奶牛为 2.04 mmol/L[95%置信区间(CI)=2.00-2.07 mmol/L],TRD 组奶牛为 2.06 mmol/L(95%CI = 2.03-2.09 mmol/L),EXP 组奶牛为 2.09 mmol/L(95%CI = 2.05-2.12 mmol/L)。与 TRD 和 EXP 组相比,CON 组奶牛首次配种妊娠风险数值更高,但无统计学差异;然而,我们的研究结果对这一结果没有足够的说服力。在我们的研究条件下,我们的研究结果表明,产后 24 小时和 48 小时延迟口服钙丸补充对前 4 个月的产奶量没有影响。